Actively Recruiting
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Led by University of Rochester · Updated on 2026-03-31
1020
Participants Needed
4
Research Sites
255 weeks
Total Duration
On this page
Sponsors
U
University of Rochester
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a multicenter randomized controlled trial that assesses the efficacy of a decisional intervention \[University of Rochester-Geriatric Oncology assessment for Acute myeloid Leukemia (UR-GOAL)\] compared to an attention control.
CONDITIONS
Official Title
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 60 years or older (confirmed from date of consent and medical records)
- New diagnosis of acute myeloid leukemia (AML) based on International Consensus Classification or World Health Organization criteria
- Myeloid sarcoma allowed
- AML with central nervous system involvement allowed
- Cancer-directed treatment has not yet started (temporary treatments to lower white blood cells like hydroxyurea, leukapheresis, cytarabine, or intrathecal chemotherapy are allowed)
- Patient's oncologist is enrolled or will be enrolled in the study
- English or Spanish speaking
- Patients without a caregiver can still participate
- Caregivers must be 18 years or older, able to give consent, and speak English or Spanish
- Caregivers may be paid/professional or informal
- Oncologists caring for AML patients can participate
You will not qualify if you...
- Diagnosis of acute promyelocytic leukemia
- Psychiatric or cognitive conditions that prevent informed consent or study compliance as judged by the treating oncologist
- Prior cancer-directed treatment for AML
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
University of Alabama at Birmingham, Division of Hematology and Oncology
Birmingham, Alabama, United States, 35233
Actively Recruiting
2
University of Rochester Medical Center
Rochester, New York, United States, 14642
Actively Recruiting
3
University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States, 27514
Actively Recruiting
4
Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Section of Hematology/Oncology
Winston-Salem, North Carolina, United States, 27157
Actively Recruiting
Research Team
K
Kah Poh Loh
CONTACT
B
Becky Gravenstede
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here